| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lyme Disease | 243 | 2024 | 631 | 28.540 |
Why?
|
| Borrelia burgdorferi | 72 | 2024 | 183 | 14.750 |
Why?
|
| Antibodies, Bacterial | 65 | 2023 | 1464 | 4.390 |
Why?
|
| Borrelia burgdorferi Group | 58 | 2016 | 97 | 4.290 |
Why?
|
| Synovial Membrane | 23 | 2019 | 532 | 4.130 |
Why?
|
| Erythema Chronicum Migrans | 26 | 2020 | 48 | 3.200 |
Why?
|
| Bacterial Outer Membrane Proteins | 26 | 2013 | 404 | 3.190 |
Why?
|
| Lipoproteins | 31 | 2013 | 879 | 3.090 |
Why?
|
| Antigens, Bacterial | 37 | 2019 | 1141 | 3.010 |
Why?
|
| Arthritis, Infectious | 46 | 2024 | 347 | 2.860 |
Why?
|
| Synovial Fluid | 38 | 2024 | 393 | 2.780 |
Why?
|
| Arthritis | 17 | 2023 | 680 | 2.610 |
Why?
|
| HLA-DR Antigens | 20 | 2021 | 601 | 2.560 |
Why?
|
| Anti-Bacterial Agents | 57 | 2024 | 7403 | 2.060 |
Why?
|
| Autoantibodies | 14 | 2024 | 2115 | 1.940 |
Why?
|
| Immunoglobulin G | 54 | 2023 | 4533 | 1.940 |
Why?
|
| Drug Resistance, Bacterial | 15 | 2015 | 1049 | 1.890 |
Why?
|
| Antigens, Surface | 21 | 2013 | 1606 | 1.790 |
Why?
|
| Immunoglobulin M | 44 | 2022 | 1526 | 1.570 |
Why?
|
| Arthritis, Rheumatoid | 20 | 2024 | 3752 | 1.570 |
Why?
|
| Leukocytes, Mononuclear | 9 | 2023 | 1834 | 1.520 |
Why?
|
| Autoantigens | 10 | 2019 | 888 | 1.460 |
Why?
|
| Epitopes, T-Lymphocyte | 9 | 2023 | 825 | 1.390 |
Why?
|
| Glossitis, Benign Migratory | 4 | 2017 | 7 | 1.150 |
Why?
|
| Bacterial Proteins | 20 | 2018 | 3842 | 1.100 |
Why?
|
| Serologic Tests | 17 | 2022 | 381 | 1.070 |
Why?
|
| Bacterial Vaccines | 20 | 2013 | 399 | 1.060 |
Why?
|
| Doxycycline | 11 | 2016 | 344 | 1.050 |
Why?
|
| Cytokines | 15 | 2024 | 7373 | 1.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 36 | 2018 | 3798 | 0.990 |
Why?
|
| Ticks | 25 | 2013 | 70 | 0.920 |
Why?
|
| Drug Resistance, Microbial | 10 | 2013 | 825 | 0.920 |
Why?
|
| Erythema | 27 | 2017 | 262 | 0.890 |
Why?
|
| Autoimmunity | 7 | 2023 | 1350 | 0.890 |
Why?
|
| Borrelia | 27 | 2008 | 66 | 0.800 |
Why?
|
| Joints | 6 | 2017 | 322 | 0.780 |
Why?
|
| T-Lymphocytes | 24 | 2019 | 10175 | 0.770 |
Why?
|
| DNA, Bacterial | 12 | 2009 | 1471 | 0.760 |
Why?
|
| Prevotella | 2 | 2021 | 80 | 0.760 |
Why?
|
| Endothelial Growth Factors | 2 | 2014 | 673 | 0.740 |
Why?
|
| B-Lymphocytes | 13 | 2016 | 4745 | 0.740 |
Why?
|
| Lyme Neuroborreliosis | 5 | 2020 | 50 | 0.700 |
Why?
|
| Chronic Periodontitis | 1 | 2021 | 101 | 0.680 |
Why?
|
| Epitopes | 7 | 2021 | 2501 | 0.680 |
Why?
|
| Ixodes | 6 | 2024 | 40 | 0.670 |
Why?
|
| Th17 Cells | 5 | 2024 | 793 | 0.650 |
Why?
|
| Synovitis | 5 | 2019 | 217 | 0.640 |
Why?
|
| Ceftriaxone | 10 | 2007 | 175 | 0.630 |
Why?
|
| Arthritis, Reactive | 3 | 2017 | 20 | 0.630 |
Why?
|
| Amoxicillin | 5 | 2016 | 181 | 0.600 |
Why?
|
| Acrodermatitis | 5 | 2007 | 15 | 0.600 |
Why?
|
| Th1 Cells | 6 | 2018 | 1027 | 0.600 |
Why?
|
| Lyme Disease Vaccines | 8 | 2011 | 18 | 0.590 |
Why?
|
| Interferon-gamma | 7 | 2019 | 3145 | 0.590 |
Why?
|
| Chemokines | 4 | 2017 | 954 | 0.580 |
Why?
|
| Humans | 297 | 2024 | 760740 | 0.570 |
Why?
|
| Chemokines, CXC | 3 | 2008 | 416 | 0.570 |
Why?
|
| Autoimmune Diseases | 3 | 2021 | 2238 | 0.570 |
Why?
|
| Matrix Metalloproteinase 10 | 1 | 2016 | 11 | 0.530 |
Why?
|
| Polymerase Chain Reaction | 15 | 2019 | 6074 | 0.530 |
Why?
|
| Spondylarthritis | 1 | 2017 | 61 | 0.520 |
Why?
|
| Nervous System Diseases | 14 | 2020 | 1662 | 0.510 |
Why?
|
| Annexin A2 | 1 | 2015 | 43 | 0.500 |
Why?
|
| Immunoglobulin A | 6 | 2023 | 978 | 0.490 |
Why?
|
| Apolipoprotein B-100 | 1 | 2015 | 157 | 0.470 |
Why?
|
| Immunoenzyme Techniques | 7 | 2018 | 1703 | 0.470 |
Why?
|
| Arthritis, Psoriatic | 1 | 2017 | 219 | 0.450 |
Why?
|
| Bacteroidaceae Infections | 1 | 2013 | 31 | 0.420 |
Why?
|
| Peptides | 9 | 2023 | 4354 | 0.420 |
Why?
|
| DNA, Ribosomal Spacer | 2 | 2009 | 28 | 0.410 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2012 | 48 | 0.400 |
Why?
|
| Blotting, Western | 18 | 2011 | 5034 | 0.400 |
Why?
|
| Porphyromonas gingivalis | 1 | 2013 | 164 | 0.400 |
Why?
|
| Macrophage Activation | 3 | 2011 | 552 | 0.390 |
Why?
|
| Rheumatology | 4 | 2021 | 615 | 0.380 |
Why?
|
| Child | 75 | 2022 | 80089 | 0.380 |
Why?
|
| Adult | 121 | 2024 | 220995 | 0.380 |
Why?
|
| Skin | 12 | 2017 | 4472 | 0.370 |
Why?
|
| Inflammation | 6 | 2021 | 10759 | 0.370 |
Why?
|
| Osteoarthritis | 2 | 2018 | 1063 | 0.370 |
Why?
|
| Complementary Therapies | 1 | 2015 | 486 | 0.370 |
Why?
|
| Adolescent | 72 | 2018 | 88247 | 0.360 |
Why?
|
| Middle Aged | 105 | 2024 | 220603 | 0.360 |
Why?
|
| Clinical Laboratory Techniques | 4 | 2021 | 745 | 0.360 |
Why?
|
| Arachnid Vectors | 11 | 2006 | 24 | 0.360 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 5 | 2003 | 378 | 0.350 |
Why?
|
| Natural Killer T-Cells | 1 | 2013 | 322 | 0.350 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2021 | 1186 | 0.350 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2160 | 0.340 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2008 | 767 | 0.330 |
Why?
|
| Interleukin-23 | 4 | 2014 | 201 | 0.320 |
Why?
|
| Heart Diseases | 3 | 2020 | 2778 | 0.320 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 105 | 0.320 |
Why?
|
| Bites and Stings | 10 | 2017 | 93 | 0.320 |
Why?
|
| Fibroblasts | 2 | 2019 | 4140 | 0.320 |
Why?
|
| Macrophages | 8 | 2017 | 5758 | 0.310 |
Why?
|
| Brain Diseases | 7 | 1999 | 1546 | 0.310 |
Why?
|
| Cerebrospinal Fluid | 5 | 2007 | 544 | 0.310 |
Why?
|
| Immunity, Cellular | 8 | 2017 | 1550 | 0.310 |
Why?
|
| Sensitivity and Specificity | 21 | 2022 | 14649 | 0.300 |
Why?
|
| Glycolipids | 1 | 2009 | 206 | 0.300 |
Why?
|
| Facial Paralysis | 4 | 2005 | 346 | 0.300 |
Why?
|
| Spirochaetales | 12 | 2007 | 26 | 0.300 |
Why?
|
| Male | 121 | 2024 | 360402 | 0.300 |
Why?
|
| Aged | 67 | 2024 | 169092 | 0.290 |
Why?
|
| Pseudolymphoma | 1 | 2007 | 30 | 0.290 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2008 | 2747 | 0.290 |
Why?
|
| Monokines | 1 | 2007 | 71 | 0.290 |
Why?
|
| Antigen Presentation | 5 | 2019 | 1250 | 0.290 |
Why?
|
| Female | 119 | 2024 | 392203 | 0.280 |
Why?
|
| Travel | 1 | 2013 | 796 | 0.280 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 4 | 2024 | 974 | 0.270 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 1999 | 200 | 0.270 |
Why?
|
| HLA-DR4 Antigen | 4 | 2001 | 22 | 0.270 |
Why?
|
| Erythromycin | 4 | 1992 | 115 | 0.270 |
Why?
|
| Molecular Mimicry | 3 | 2004 | 213 | 0.260 |
Why?
|
| Europe | 8 | 2018 | 3415 | 0.260 |
Why?
|
| Cell Proliferation | 5 | 2015 | 10429 | 0.260 |
Why?
|
| Young Adult | 17 | 2024 | 59191 | 0.260 |
Why?
|
| Antibody Formation | 7 | 2013 | 1390 | 0.260 |
Why?
|
| Rheumatoid Factor | 6 | 2023 | 184 | 0.250 |
Why?
|
| Connecticut | 15 | 2006 | 364 | 0.240 |
Why?
|
| Enzyme-Linked Immunospot Assay | 2 | 2017 | 123 | 0.240 |
Why?
|
| Up-Regulation | 2 | 2013 | 4117 | 0.240 |
Why?
|
| Adaptive Immunity | 3 | 2019 | 724 | 0.240 |
Why?
|
| Saliva | 2 | 2021 | 828 | 0.230 |
Why?
|
| Central Nervous System Diseases | 4 | 1998 | 521 | 0.230 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 2191 | 0.230 |
Why?
|
| Neurology | 3 | 2021 | 784 | 0.230 |
Why?
|
| Cephalosporins | 4 | 1999 | 198 | 0.230 |
Why?
|
| Peptide Fragments | 6 | 2007 | 5109 | 0.230 |
Why?
|
| Monocytes | 4 | 2011 | 2565 | 0.230 |
Why?
|
| Immunoassay | 3 | 2017 | 744 | 0.220 |
Why?
|
| Fibromyalgia | 5 | 2002 | 405 | 0.220 |
Why?
|
| Anaplasma | 1 | 2003 | 5 | 0.220 |
Why?
|
| Probenecid | 2 | 1994 | 73 | 0.220 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1884 | 0.210 |
Why?
|
| RNA, Messenger | 6 | 2018 | 12759 | 0.210 |
Why?
|
| Tetracycline | 7 | 1988 | 216 | 0.210 |
Why?
|
| Antigens, CD1 | 2 | 2019 | 439 | 0.210 |
Why?
|
| Fucose | 1 | 2023 | 122 | 0.210 |
Why?
|
| Immunity, Innate | 4 | 2018 | 3045 | 0.210 |
Why?
|
| Internet | 1 | 2015 | 3094 | 0.210 |
Why?
|
| Communicable Diseases | 2 | 2021 | 871 | 0.200 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 5463 | 0.200 |
Why?
|
| Galactose | 1 | 2023 | 294 | 0.200 |
Why?
|
| Cell Lineage | 1 | 2010 | 2553 | 0.190 |
Why?
|
| United States | 31 | 2021 | 72292 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2022 | 1810 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2017 | 3802 | 0.180 |
Why?
|
| Gingival Crevicular Fluid | 1 | 2021 | 94 | 0.180 |
Why?
|
| History, 20th Century | 3 | 2024 | 2764 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 5 | 2013 | 3077 | 0.180 |
Why?
|
| Time Factors | 25 | 2017 | 39908 | 0.180 |
Why?
|
| Algorithms | 5 | 2022 | 14024 | 0.170 |
Why?
|
| Spirochaetales Infections | 6 | 1984 | 11 | 0.170 |
Why?
|
| Glycosylation | 1 | 2023 | 1098 | 0.170 |
Why?
|
| Chemokine CXCL9 | 2 | 2012 | 135 | 0.170 |
Why?
|
| Penicillin G | 4 | 1988 | 40 | 0.170 |
Why?
|
| Genotype | 6 | 2023 | 12977 | 0.170 |
Why?
|
| Animals | 49 | 2024 | 168202 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 799 | 0.160 |
Why?
|
| Peripheral Nervous System Diseases | 5 | 1993 | 709 | 0.160 |
Why?
|
| Cross Reactions | 9 | 2019 | 816 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 15908 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 829 | 0.160 |
Why?
|
| Borrelia Infections | 4 | 1988 | 17 | 0.160 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 1365 | 0.160 |
Why?
|
| Chemokine CXCL10 | 2 | 2012 | 309 | 0.160 |
Why?
|
| Chronic Disease | 21 | 2011 | 9310 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2023 | 4365 | 0.150 |
Why?
|
| Rodent Diseases | 2 | 2008 | 53 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2024 | 1566 | 0.150 |
Why?
|
| Injections, Intra-Articular | 1 | 2019 | 280 | 0.150 |
Why?
|
| Plasma Cells | 3 | 2018 | 597 | 0.150 |
Why?
|
| Optic Nerve Diseases | 1 | 2001 | 342 | 0.150 |
Why?
|
| Knee Joint | 6 | 2007 | 1676 | 0.150 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2017 | 14 | 0.140 |
Why?
|
| Sulfatases | 1 | 2017 | 44 | 0.140 |
Why?
|
| Myocarditis | 4 | 2020 | 788 | 0.140 |
Why?
|
| Peptidoglycan | 1 | 2019 | 248 | 0.140 |
Why?
|
| Cefuroxime | 1 | 2016 | 23 | 0.140 |
Why?
|
| Drug Therapy, Combination | 4 | 2003 | 6305 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 11069 | 0.140 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2016 | 138 | 0.140 |
Why?
|
| Cells, Cultured | 11 | 2012 | 18937 | 0.140 |
Why?
|
| Molecular Sequence Data | 11 | 2010 | 17630 | 0.140 |
Why?
|
| Base Sequence | 8 | 2018 | 12420 | 0.130 |
Why?
|
| Peptides, Cyclic | 2 | 2023 | 392 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2023 | 1013 | 0.130 |
Why?
|
| Bacteriological Techniques | 3 | 2002 | 275 | 0.130 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 299 | 0.130 |
Why?
|
| Matrix Metalloproteinases | 3 | 2005 | 391 | 0.130 |
Why?
|
| Cardiolipins | 2 | 1993 | 81 | 0.130 |
Why?
|
| Penicillin V | 2 | 1987 | 18 | 0.130 |
Why?
|
| Zoonoses | 1 | 2016 | 179 | 0.130 |
Why?
|
| Convalescence | 3 | 2008 | 106 | 0.130 |
Why?
|
| Vaccines, Synthetic | 1 | 1998 | 612 | 0.130 |
Why?
|
| Case-Control Studies | 7 | 2018 | 22153 | 0.120 |
Why?
|
| Syndrome | 3 | 2020 | 3268 | 0.120 |
Why?
|
| beta-Lactams | 1 | 2016 | 155 | 0.120 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1995 | 340 | 0.120 |
Why?
|
| Early Diagnosis | 2 | 2017 | 1185 | 0.120 |
Why?
|
| Anaplasmosis | 2 | 2006 | 37 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2001 | 1602 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 58919 | 0.120 |
Why?
|
| Gene Frequency | 3 | 2006 | 3601 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2019 | 786 | 0.110 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1993 | 62 | 0.110 |
Why?
|
| Cranial Nerve Diseases | 4 | 2007 | 110 | 0.110 |
Why?
|
| HLA-DR2 Antigen | 2 | 1990 | 44 | 0.110 |
Why?
|
| Drug Resistance | 3 | 2016 | 1594 | 0.110 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5863 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2018 | 1056 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2010 | 13442 | 0.110 |
Why?
|
| Gangliosides | 1 | 1993 | 132 | 0.100 |
Why?
|
| Cross Infection | 7 | 1981 | 1422 | 0.100 |
Why?
|
| Diagnosis, Differential | 14 | 2007 | 12966 | 0.100 |
Why?
|
| Interleukin-1 | 2 | 1993 | 1248 | 0.100 |
Why?
|
| Exanthema | 1 | 2016 | 503 | 0.100 |
Why?
|
| Blood Sedimentation | 1 | 2013 | 235 | 0.100 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1993 | 262 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2010 | 1797 | 0.100 |
Why?
|
| Societies, Medical | 2 | 2020 | 3901 | 0.100 |
Why?
|
| Child, Preschool | 26 | 2004 | 42193 | 0.100 |
Why?
|
| Fatigue Syndrome, Chronic | 3 | 2002 | 215 | 0.090 |
Why?
|
| Meningitis | 4 | 1986 | 217 | 0.090 |
Why?
|
| Professional Misconduct | 1 | 2011 | 73 | 0.090 |
Why?
|
| Consumer Advocacy | 1 | 2011 | 82 | 0.090 |
Why?
|
| Injections, Intravenous | 5 | 1999 | 1376 | 0.090 |
Why?
|
| Bacterial Load | 1 | 2011 | 151 | 0.090 |
Why?
|
| Cryoglobulins | 4 | 1980 | 58 | 0.090 |
Why?
|
| RNA | 1 | 2000 | 2713 | 0.090 |
Why?
|
| Adrenomedullin | 1 | 2010 | 85 | 0.090 |
Why?
|
| Interleukin-1beta | 3 | 2011 | 998 | 0.090 |
Why?
|
| Slovenia | 1 | 2009 | 22 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2013 | 1646 | 0.090 |
Why?
|
| Blindness | 3 | 2001 | 585 | 0.090 |
Why?
|
| Memory Disorders | 2 | 1999 | 1197 | 0.090 |
Why?
|
| Keratitis | 2 | 1991 | 241 | 0.080 |
Why?
|
| Disease Outbreaks | 6 | 1979 | 1748 | 0.080 |
Why?
|
| North America | 3 | 2021 | 1273 | 0.080 |
Why?
|
| Penicillins | 7 | 1997 | 402 | 0.080 |
Why?
|
| Serotyping | 1 | 2010 | 325 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4570 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 9417 | 0.080 |
Why?
|
| Population Surveillance | 4 | 1993 | 2597 | 0.080 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 263 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 3680 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 4 | 2019 | 6188 | 0.080 |
Why?
|
| Babesiosis | 2 | 2006 | 92 | 0.080 |
Why?
|
| Palatine Tonsil | 2 | 1988 | 193 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2014 | 2635 | 0.080 |
Why?
|
| Protein Binding | 3 | 2019 | 9345 | 0.070 |
Why?
|
| Sonication | 1 | 2008 | 79 | 0.070 |
Why?
|
| Membrane Lipids | 1 | 2009 | 252 | 0.070 |
Why?
|
| Antigen-Antibody Complex | 5 | 1984 | 509 | 0.070 |
Why?
|
| Disease Models, Animal | 6 | 2006 | 18220 | 0.070 |
Why?
|
| Austria | 1 | 2008 | 206 | 0.070 |
Why?
|
| Vitreous Body | 2 | 1986 | 399 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 7390 | 0.070 |
Why?
|
| Chemokine CXCL13 | 1 | 2007 | 59 | 0.070 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 506 | 0.070 |
Why?
|
| Cognition Disorders | 2 | 1999 | 3979 | 0.070 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2006 | 19 | 0.070 |
Why?
|
| Immunity, Humoral | 1 | 2011 | 600 | 0.070 |
Why?
|
| Lymphoid Tissue | 1 | 1988 | 445 | 0.070 |
Why?
|
| Tick-Borne Diseases | 1 | 2006 | 36 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 399 | 0.070 |
Why?
|
| Prospective Studies | 16 | 2022 | 54364 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3634 | 0.070 |
Why?
|
| Chondrocytes | 3 | 2006 | 792 | 0.070 |
Why?
|
| Iritis | 1 | 1985 | 15 | 0.070 |
Why?
|
| Panophthalmitis | 1 | 1985 | 6 | 0.070 |
Why?
|
| Syphilis | 4 | 1999 | 243 | 0.060 |
Why?
|
| Neuritis | 2 | 1985 | 35 | 0.060 |
Why?
|
| Paralysis | 1 | 2007 | 250 | 0.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2005 | 18 | 0.060 |
Why?
|
| Double-Blind Method | 6 | 2003 | 12333 | 0.060 |
Why?
|
| ROC Curve | 2 | 2011 | 3575 | 0.060 |
Why?
|
| Myositis | 1 | 1988 | 269 | 0.060 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2005 | 33 | 0.060 |
Why?
|
| Computers | 1 | 2008 | 591 | 0.060 |
Why?
|
| Antibody Diversity | 1 | 2005 | 72 | 0.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2005 | 91 | 0.060 |
Why?
|
| Recombinant Proteins | 4 | 2018 | 6520 | 0.060 |
Why?
|
| ADAM Proteins | 1 | 2006 | 238 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 11874 | 0.060 |
Why?
|
| Retinal Vasculitis | 1 | 2005 | 46 | 0.060 |
Why?
|
| Cell Separation | 1 | 2010 | 1718 | 0.060 |
Why?
|
| Acute Disease | 6 | 2001 | 7236 | 0.060 |
Why?
|
| Dog Diseases | 1 | 1985 | 141 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2108 | 0.060 |
Why?
|
| Immunodominant Epitopes | 3 | 1999 | 238 | 0.060 |
Why?
|
| Russia | 2 | 1995 | 382 | 0.060 |
Why?
|
| Serum Albumin | 2 | 1978 | 673 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 1997 | 3030 | 0.060 |
Why?
|
| DNA Primers | 3 | 1999 | 2817 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2567 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1454 | 0.060 |
Why?
|
| Muscle Weakness | 1 | 2007 | 412 | 0.060 |
Why?
|
| Massachusetts | 4 | 2010 | 8835 | 0.060 |
Why?
|
| Heart Block | 3 | 1986 | 384 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 26065 | 0.060 |
Why?
|
| Virulence | 2 | 2006 | 1299 | 0.050 |
Why?
|
| Muscles | 1 | 1988 | 1573 | 0.050 |
Why?
|
| Molecular Weight | 3 | 1994 | 2185 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2015 | 41464 | 0.050 |
Why?
|
| Radiculopathy | 2 | 1985 | 201 | 0.050 |
Why?
|
| Vasculitis | 2 | 2005 | 522 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 565 | 0.050 |
Why?
|
| Drug Administration Schedule | 3 | 2003 | 4845 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 1073 | 0.050 |
Why?
|
| Antigens, Differentiation | 2 | 2000 | 908 | 0.050 |
Why?
|
| Plasmids | 2 | 2023 | 2265 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2008 | 911 | 0.050 |
Why?
|
| Hand | 2 | 1980 | 902 | 0.050 |
Why?
|
| Hydroxychloroquine | 1 | 2006 | 426 | 0.050 |
Why?
|
| Rhode Island | 1 | 2003 | 351 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2006 | 2149 | 0.050 |
Why?
|
| Disease Vectors | 1 | 2001 | 61 | 0.050 |
Why?
|
| Serology | 1 | 2001 | 7 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 1141 | 0.050 |
Why?
|
| Cerebellar Ataxia | 2 | 2002 | 150 | 0.050 |
Why?
|
| Insect Repellents | 1 | 2020 | 17 | 0.050 |
Why?
|
| Flagellin | 1 | 2001 | 124 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2024 | 659 | 0.050 |
Why?
|
| Drug Contamination | 2 | 1979 | 151 | 0.050 |
Why?
|
| Porins | 1 | 2001 | 78 | 0.050 |
Why?
|
| Dermatitis | 4 | 1995 | 202 | 0.050 |
Why?
|
| Optic Atrophy | 1 | 2001 | 79 | 0.050 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2001 | 141 | 0.050 |
Why?
|
| Antigens | 1 | 1986 | 1441 | 0.050 |
Why?
|
| Integrin alpha4beta1 | 1 | 2001 | 119 | 0.050 |
Why?
|
| Mice | 14 | 2019 | 81368 | 0.050 |
Why?
|
| Depressive Disorder | 2 | 1999 | 3735 | 0.050 |
Why?
|
| Rheumatic Diseases | 1 | 1988 | 649 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2003 | 64572 | 0.050 |
Why?
|
| Infectious Disease Medicine | 1 | 2020 | 49 | 0.040 |
Why?
|
| Prostaglandins E | 1 | 1980 | 166 | 0.040 |
Why?
|
| Laboratory Infection | 1 | 1980 | 7 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2178 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2005 | 15829 | 0.040 |
Why?
|
| Recurrence | 6 | 1993 | 8426 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2005 | 3730 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 4340 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2001 | 39062 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2358 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1739 | 0.040 |
Why?
|
| Papilledema | 1 | 2001 | 130 | 0.040 |
Why?
|
| Tetracycline Resistance | 1 | 1999 | 22 | 0.040 |
Why?
|
| Microbial Collagenase | 1 | 1980 | 112 | 0.040 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15250 | 0.040 |
Why?
|
| Joint Diseases | 2 | 1987 | 459 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2007 | 1333 | 0.040 |
Why?
|
| Haplotypes | 1 | 2006 | 2713 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 2001 | 556 | 0.040 |
Why?
|
| Ocular Hypertension | 1 | 2001 | 209 | 0.040 |
Why?
|
| Neutrophils | 4 | 2017 | 3763 | 0.040 |
Why?
|
| Nurseries, Hospital | 2 | 1975 | 17 | 0.040 |
Why?
|
| Radioimmunoassay | 3 | 1991 | 861 | 0.040 |
Why?
|
| Lymphocytes | 3 | 2017 | 2604 | 0.040 |
Why?
|
| Optic Neuritis | 1 | 2001 | 174 | 0.040 |
Why?
|
| Proteomics | 1 | 2013 | 3836 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 1182 | 0.040 |
Why?
|
| Sterilization | 1 | 1980 | 132 | 0.040 |
Why?
|
| Retrospective Studies | 9 | 2022 | 80583 | 0.040 |
Why?
|
| Fishes | 1 | 2022 | 602 | 0.040 |
Why?
|
| Species Specificity | 4 | 2005 | 2410 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 1979 | 122 | 0.040 |
Why?
|
| Urinalysis | 1 | 2001 | 368 | 0.040 |
Why?
|
| Diglycerides | 1 | 2019 | 177 | 0.040 |
Why?
|
| Pain | 3 | 2007 | 5062 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 1999 | 297 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2001 | 691 | 0.040 |
Why?
|
| Meningitis, Pneumococcal | 1 | 1978 | 43 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2000 | 7050 | 0.040 |
Why?
|
| Mycobacterium | 1 | 1979 | 251 | 0.040 |
Why?
|
| Disinfection | 1 | 1980 | 207 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 5 | 1984 | 2467 | 0.040 |
Why?
|
| Fever | 3 | 2005 | 1618 | 0.040 |
Why?
|
| Immunosorbent Techniques | 2 | 1988 | 174 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 1874 | 0.040 |
Why?
|
| Neural Conduction | 2 | 1992 | 441 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 1128 | 0.040 |
Why?
|
| Interleukin-6 | 3 | 2010 | 3205 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 1998 | 227 | 0.040 |
Why?
|
| Anesthesia, Local | 1 | 1979 | 277 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1999 | 647 | 0.030 |
Why?
|
| Aspergillosis | 1 | 1979 | 242 | 0.030 |
Why?
|
| Clinical Trials as Topic | 4 | 2003 | 7995 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2020 | 852 | 0.030 |
Why?
|
| Coloring Agents | 1 | 1979 | 562 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2270 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1993 | 1738 | 0.030 |
Why?
|
| Paraproteinemias | 1 | 1979 | 248 | 0.030 |
Why?
|
| Integrins | 1 | 2001 | 834 | 0.030 |
Why?
|
| Rats, Inbred Lew | 2 | 1988 | 1157 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 100 | 0.030 |
Why?
|
| Antisepsis | 1 | 1975 | 16 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 637 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 393 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1900 | 0.030 |
Why?
|
| Endemic Diseases | 1 | 1997 | 191 | 0.030 |
Why?
|
| Computational Biology | 1 | 2008 | 3509 | 0.030 |
Why?
|
| Risk Factors | 4 | 2020 | 74128 | 0.030 |
Why?
|
| Salmonella Food Poisoning | 1 | 1975 | 12 | 0.030 |
Why?
|
| Bronchi | 1 | 1979 | 846 | 0.030 |
Why?
|
| Nose | 1 | 1979 | 521 | 0.030 |
Why?
|
| Encephalitis | 3 | 1990 | 438 | 0.030 |
Why?
|
| Germany, West | 3 | 1990 | 13 | 0.030 |
Why?
|
| Prevalence | 3 | 2003 | 15702 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2010 | 22117 | 0.030 |
Why?
|
| Clone Cells | 3 | 2005 | 1657 | 0.030 |
Why?
|
| Deer | 1 | 1994 | 14 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 1997 | 991 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1988 | 461 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 520 | 0.030 |
Why?
|
| Thymidine Phosphorylase | 1 | 2013 | 14 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1624 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 1996 | 1700 | 0.030 |
Why?
|
| Cocaine | 1 | 1979 | 958 | 0.030 |
Why?
|
| Photopheresis | 1 | 1994 | 35 | 0.030 |
Why?
|
| HLA Antigens | 1 | 1999 | 1327 | 0.030 |
Why?
|
| Headache | 1 | 2002 | 1255 | 0.030 |
Why?
|
| Streptococcus agalactiae | 1 | 1975 | 337 | 0.030 |
Why?
|
| Leukocytes | 2 | 2000 | 2024 | 0.030 |
Why?
|
| Myocardium | 1 | 1986 | 4725 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 2 | 1982 | 1272 | 0.030 |
Why?
|
| Salmonella Infections | 1 | 1975 | 172 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1999 | 823 | 0.030 |
Why?
|
| Complement C3 | 4 | 1984 | 434 | 0.030 |
Why?
|
| Isoantigens | 3 | 1980 | 551 | 0.030 |
Why?
|
| Electromyography | 2 | 1992 | 1392 | 0.030 |
Why?
|
| Physicians | 1 | 2011 | 4583 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1993 | 213 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 933 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 411 | 0.030 |
Why?
|
| Dendritic Cells | 2 | 2017 | 2722 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1998 | 990 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 1999 | 2152 | 0.030 |
Why?
|
| DNA Probes | 1 | 1994 | 541 | 0.030 |
Why?
|
| Edema | 2 | 1989 | 765 | 0.030 |
Why?
|
| Space-Time Clustering | 2 | 1986 | 45 | 0.030 |
Why?
|
| Random Allocation | 3 | 1989 | 2392 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1068 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1979 | 831 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 1998 | 1171 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1996 | 793 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 4 | 1998 | 5493 | 0.020 |
Why?
|
| Propaganda | 1 | 2011 | 7 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 306 | 0.020 |
Why?
|
| Epidemiologic Methods | 3 | 1986 | 1335 | 0.020 |
Why?
|
| Leg Dermatoses | 1 | 1991 | 20 | 0.020 |
Why?
|
| Age Factors | 3 | 2001 | 18381 | 0.020 |
Why?
|
| Germany | 1 | 1994 | 872 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 1992 | 315 | 0.020 |
Why?
|
| Biopsy | 3 | 2017 | 6763 | 0.020 |
Why?
|
| Hand Dermatoses | 1 | 1991 | 62 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 13495 | 0.020 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1993 | 165 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 1975 | 617 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3117 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1993 | 393 | 0.020 |
Why?
|
| Pigmentation Disorders | 1 | 1991 | 105 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2010 | 106 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4569 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 1993 | 221 | 0.020 |
Why?
|
| Azithromycin | 1 | 1992 | 199 | 0.020 |
Why?
|
| Chemotactic Factors | 1 | 1991 | 197 | 0.020 |
Why?
|
| Leukemia | 1 | 1979 | 1520 | 0.020 |
Why?
|
| Diagnostic Errors | 2 | 1993 | 1265 | 0.020 |
Why?
|
| Pregnancy | 6 | 2006 | 29869 | 0.020 |
Why?
|
| Reference Values | 1 | 1997 | 4919 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1993 | 915 | 0.020 |
Why?
|
| Complement C4 | 3 | 1984 | 216 | 0.020 |
Why?
|
| Sensation | 1 | 1992 | 336 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 2005 | 452 | 0.020 |
Why?
|
| Seasons | 4 | 1985 | 1518 | 0.020 |
Why?
|
| Complement C1 | 2 | 1979 | 31 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 2546 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1988 | 2088 | 0.020 |
Why?
|
| Leptospira | 2 | 1986 | 13 | 0.020 |
Why?
|
| Corneal Opacity | 1 | 1989 | 47 | 0.020 |
Why?
|
| Cartilage | 2 | 2005 | 806 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 1994 | 2202 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 345 | 0.020 |
Why?
|
| Peromyscus | 1 | 2008 | 16 | 0.020 |
Why?
|
| Musculoskeletal Diseases | 1 | 1994 | 597 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2805 | 0.020 |
Why?
|
| Cattle | 2 | 2006 | 3841 | 0.020 |
Why?
|
| Alleles | 1 | 1999 | 6861 | 0.020 |
Why?
|
| Soaps | 2 | 1980 | 29 | 0.020 |
Why?
|
| Ankle | 1 | 1991 | 350 | 0.020 |
Why?
|
| Mononuclear Phagocyte System | 1 | 1988 | 53 | 0.020 |
Why?
|
| Spirochaetaceae | 2 | 1984 | 4 | 0.020 |
Why?
|
| Endothelium | 2 | 1988 | 764 | 0.020 |
Why?
|
| Endothelium, Lymphatic | 1 | 1988 | 63 | 0.020 |
Why?
|
| Microspheres | 1 | 2011 | 782 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1991 | 850 | 0.020 |
Why?
|
| Risk | 4 | 1997 | 9603 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1997 | 2726 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 1999 | 14599 | 0.020 |
Why?
|
| Detergents | 2 | 1980 | 236 | 0.020 |
Why?
|
| Incidence | 2 | 1997 | 21339 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 888 | 0.020 |
Why?
|
| Purpura | 2 | 2005 | 117 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1994 | 6223 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 1 | 2008 | 280 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 1991 | 1788 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1991 | 1434 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2007 | 186 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 1988 | 826 | 0.020 |
Why?
|
| Ehrlichiosis | 1 | 2006 | 28 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1992 | 1131 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2001 | 631 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2017 | 3998 | 0.020 |
Why?
|
| Cartilage, Articular | 2 | 2006 | 1099 | 0.020 |
Why?
|
| Mental Disorders | 2 | 1997 | 6826 | 0.020 |
Why?
|
| Atrophy | 1 | 1991 | 1632 | 0.020 |
Why?
|
| Personnel, Hospital | 2 | 1981 | 285 | 0.020 |
Why?
|
| Urban Population | 1 | 1994 | 2034 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2001 | 6561 | 0.020 |
Why?
|
| Decision Trees | 2 | 1998 | 504 | 0.020 |
Why?
|
| Lymphocyte Count | 2 | 1998 | 777 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 36401 | 0.020 |
Why?
|
| Rats | 4 | 1994 | 23716 | 0.020 |
Why?
|
| Blood | 2 | 1991 | 596 | 0.020 |
Why?
|
| Pilonidal Sinus | 1 | 2005 | 16 | 0.020 |
Why?
|
| Reaction Time | 1 | 1992 | 2087 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 913 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 1985 | 45 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1994 | 2135 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1992 | 2100 | 0.020 |
Why?
|
| Health Surveys | 1 | 1995 | 4036 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 1987 | 282 | 0.020 |
Why?
|
| New Jersey | 1 | 1985 | 295 | 0.010 |
Why?
|
| Injections | 1 | 1988 | 832 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 2005 | 289 | 0.010 |
Why?
|
| Polyradiculoneuropathy | 1 | 1984 | 65 | 0.010 |
Why?
|
| Arthroscopy | 1 | 1991 | 969 | 0.010 |
Why?
|
| Relapsing Fever | 1 | 1984 | 24 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 427 | 0.010 |
Why?
|
| Leptospirosis | 1 | 1984 | 31 | 0.010 |
Why?
|
| Fatigue | 1 | 1991 | 1550 | 0.010 |
Why?
|
| Electrophoresis, Paper | 1 | 1983 | 14 | 0.010 |
Why?
|
| Skin Manifestations | 1 | 1983 | 17 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 1985 | 337 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1985 | 242 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7569 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2005 | 419 | 0.010 |
Why?
|
| Tick Infestations | 1 | 1983 | 9 | 0.010 |
Why?
|
| Gastroscopy | 1 | 1985 | 211 | 0.010 |
Why?
|
| Brain | 3 | 1999 | 27100 | 0.010 |
Why?
|
| Rabbits | 3 | 1984 | 4770 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1983 | 337 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2011 | 2200 | 0.010 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1985 | 258 | 0.010 |
Why?
|
| Genomics | 1 | 2019 | 5822 | 0.010 |
Why?
|
| Sepsis | 1 | 1977 | 2585 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11512 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 1985 | 398 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2003 | 135 | 0.010 |
Why?
|
| Infectious Mononucleosis | 1 | 1983 | 133 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 1971 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1979 | 299 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1984 | 1057 | 0.010 |
Why?
|
| Culture Media | 1 | 1984 | 895 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1759 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1992 | 6016 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1169 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1994 | 4210 | 0.010 |
Why?
|
| Cholestasis | 1 | 1985 | 378 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1997 | 4483 | 0.010 |
Why?
|
| Cornea | 1 | 1989 | 1332 | 0.010 |
Why?
|
| Antibodies | 3 | 1998 | 2413 | 0.010 |
Why?
|
| Radiography | 2 | 1985 | 6961 | 0.010 |
Why?
|
| Cell Line | 2 | 2010 | 15577 | 0.010 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2001 | 56 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2001 | 145 | 0.010 |
Why?
|
| District of Columbia | 1 | 2001 | 159 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 1962 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1997 | 2214 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 531 | 0.010 |
Why?
|
| Treponema | 3 | 1984 | 38 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 359 | 0.010 |
Why?
|
| Dogs | 1 | 1985 | 3837 | 0.010 |
Why?
|
| Rheumatic Fever | 1 | 1980 | 73 | 0.010 |
Why?
|
| Hybridomas | 1 | 2001 | 442 | 0.010 |
Why?
|
| Biopolymers | 1 | 2000 | 183 | 0.010 |
Why?
|
| Prognosis | 3 | 1993 | 29601 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1979 | 94 | 0.010 |
Why?
|
| Lipids | 1 | 2011 | 3332 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1979 | 141 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1983 | 418 | 0.010 |
Why?
|
| Antigenic Variation | 1 | 1999 | 118 | 0.010 |
Why?
|
| Visual Acuity | 1 | 1989 | 2676 | 0.010 |
Why?
|
| Meningitis, Meningococcal | 1 | 1979 | 43 | 0.010 |
Why?
|
| Carbenicillin | 1 | 1979 | 12 | 0.010 |
Why?
|
| Goats | 1 | 1979 | 165 | 0.010 |
Why?
|
| Aspergillus flavus | 1 | 1979 | 14 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23974 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1988 | 1094 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1979 | 97 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 1989 | 2644 | 0.010 |
Why?
|
| Prednisone | 1 | 1983 | 1562 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1983 | 552 | 0.010 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1999 | 72 | 0.010 |
Why?
|
| Arthropod Vectors | 1 | 1978 | 6 | 0.010 |
Why?
|
| Neurologic Manifestations | 1 | 1978 | 19 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1992 | 8619 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1978 | 114 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1982 | 407 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7847 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1979 | 384 | 0.010 |
Why?
|
| Disinfectants | 1 | 1980 | 129 | 0.010 |
Why?
|
| Knee | 1 | 1980 | 279 | 0.010 |
Why?
|
| Limulus Test | 1 | 1978 | 19 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2001 | 607 | 0.010 |
Why?
|
| Pseudomonas Infections | 1 | 1982 | 621 | 0.010 |
Why?
|
| Collagen | 1 | 2006 | 2634 | 0.010 |
Why?
|
| Gelatinases | 1 | 1998 | 88 | 0.010 |
Why?
|
| Hip Joint | 1 | 1985 | 1014 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1989 | 1462 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 3793 | 0.010 |
Why?
|
| Shoulder Joint | 1 | 1985 | 742 | 0.010 |
Why?
|
| Vision Disorders | 1 | 2005 | 1088 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1978 | 2234 | 0.010 |
Why?
|
| Nalidixic Acid | 1 | 1977 | 18 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1978 | 397 | 0.010 |
Why?
|
| Tetanus Toxoid | 1 | 1998 | 188 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1977 | 67 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 1979 | 157 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2001 | 774 | 0.010 |
Why?
|
| Collagenases | 1 | 1998 | 222 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1979 | 703 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2001 | 9526 | 0.010 |
Why?
|
| Abdomen | 1 | 1983 | 1128 | 0.010 |
Why?
|
| Colon | 1 | 2005 | 1791 | 0.010 |
Why?
|
| Pseudomonas | 1 | 1977 | 124 | 0.010 |
Why?
|
| Sputum | 1 | 1979 | 506 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1987 | 3769 | 0.010 |
Why?
|
| Insect Bites and Stings | 1 | 1977 | 71 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4110 | 0.010 |
Why?
|
| Cell Movement | 1 | 1988 | 5201 | 0.010 |
Why?
|
| Hexachlorophene | 1 | 1975 | 5 | 0.010 |
Why?
|
| Leukocyte Count | 3 | 1984 | 1597 | 0.010 |
Why?
|
| Iodophors | 1 | 1975 | 7 | 0.010 |
Why?
|
| Benzalkonium Compounds | 1 | 1975 | 21 | 0.010 |
Why?
|
| Gloves, Surgical | 1 | 1975 | 24 | 0.010 |
Why?
|
| Infant, Newborn | 4 | 1986 | 26183 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 1998 | 459 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1981 | 704 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 4237 | 0.010 |
Why?
|
| Staphylococcus | 1 | 1975 | 153 | 0.010 |
Why?
|
| Food Service, Hospital | 1 | 1975 | 18 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 1998 | 577 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 16572 | 0.010 |
Why?
|
| Cancer Care Facilities | 1 | 1978 | 422 | 0.010 |
Why?
|
| Silver Staining | 1 | 1994 | 62 | 0.010 |
Why?
|
| Maine | 1 | 1975 | 146 | 0.010 |
Why?
|
| Adenoma | 1 | 1985 | 2159 | 0.010 |
Why?
|
| Chlorhexidine | 1 | 1975 | 160 | 0.010 |
Why?
|
| Nitrites | 1 | 1994 | 159 | 0.010 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 149 | 0.010 |
Why?
|
| Eggs | 1 | 1975 | 182 | 0.010 |
Why?
|
| Nails | 1 | 1975 | 296 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 1979 | 909 | 0.010 |
Why?
|
| Iodine | 1 | 1975 | 287 | 0.010 |
Why?
|
| Cytosine | 2 | 1984 | 211 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1986 | 2561 | 0.010 |
Why?
|
| Guanine | 2 | 1984 | 278 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1999 | 2328 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2005 | 1921 | 0.010 |
Why?
|
| Health Personnel | 1 | 2006 | 3333 | 0.010 |
Why?
|
| Chickens | 1 | 1975 | 858 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1975 | 347 | 0.010 |
Why?
|
| Heart | 1 | 1985 | 4403 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2001 | 20077 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1985 | 5965 | 0.010 |
Why?
|
| Milk | 1 | 1975 | 442 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1980 | 1389 | 0.010 |
Why?
|
| Serial Passage | 1 | 1991 | 23 | 0.010 |
Why?
|
| Oligoclonal Bands | 1 | 1991 | 17 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1987 | 6240 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1991 | 150 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 908 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1992 | 299 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 416 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1998 | 1242 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1988 | 9171 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1991 | 190 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 1997 | 1723 | 0.010 |
Why?
|
| Catheterization | 1 | 1975 | 1428 | 0.010 |
Why?
|
| Infant | 2 | 1986 | 36157 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1980 | 2565 | 0.010 |
Why?
|
| Ethanol | 1 | 1975 | 1320 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1997 | 4010 | 0.010 |
Why?
|
| USSR | 1 | 1988 | 18 | 0.010 |
Why?
|
| Agglutination Tests | 1 | 1988 | 41 | 0.000 |
Why?
|
| Insect Vectors | 1 | 1989 | 136 | 0.000 |
Why?
|
| Organ Culture Techniques | 1 | 1991 | 794 | 0.000 |
Why?
|
| Physical Examination | 1 | 1994 | 1254 | 0.000 |
Why?
|
| Patients | 1 | 1975 | 906 | 0.000 |
Why?
|
| Feces | 1 | 1975 | 1490 | 0.000 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1988 | 158 | 0.000 |
Why?
|
| Diarrhea | 1 | 1975 | 1317 | 0.000 |
Why?
|
| Brazil | 1 | 1992 | 1229 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2011 | 23415 | 0.000 |
Why?
|
| Anxiety Disorders | 1 | 1999 | 2724 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1975 | 1457 | 0.000 |
Why?
|
| Cebidae | 1 | 1986 | 21 | 0.000 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1988 | 355 | 0.000 |
Why?
|
| Mitogens | 1 | 1986 | 229 | 0.000 |
Why?
|
| Syndactyly | 1 | 1986 | 74 | 0.000 |
Why?
|
| Lymph Nodes | 2 | 1988 | 3461 | 0.000 |
Why?
|
| Drug Costs | 1 | 1993 | 1183 | 0.000 |
Why?
|
| Nurses | 1 | 1975 | 2477 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1991 | 1526 | 0.000 |
Why?
|
| Phytohemagglutinins | 1 | 1984 | 165 | 0.000 |
Why?
|
| Complement Activating Enzymes | 1 | 1984 | 22 | 0.000 |
Why?
|
| Psychometrics | 1 | 1994 | 3062 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1986 | 1310 | 0.000 |
Why?
|
| Cardiovascular Abnormalities | 1 | 1985 | 143 | 0.000 |
Why?
|
| Urinary Bladder | 1 | 1991 | 1151 | 0.000 |
Why?
|
| Fetal Death | 1 | 1986 | 435 | 0.000 |
Why?
|
| Base Composition | 1 | 1984 | 290 | 0.000 |
Why?
|
| Complement C1q | 1 | 1984 | 93 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1975 | 1924 | 0.000 |
Why?
|
| Arterioles | 1 | 1985 | 250 | 0.000 |
Why?
|
| Pericarditis | 1 | 1985 | 134 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1985 | 696 | 0.000 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1986 | 582 | 0.000 |
Why?
|
| Disease Reservoirs | 1 | 1984 | 121 | 0.000 |
Why?
|
| Sweden | 1 | 1986 | 1379 | 0.000 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1986 | 730 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 8165 | 0.000 |
Why?
|
| Antibodies, Heterophile | 1 | 1983 | 128 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1984 | 1301 | 0.000 |
Why?
|
| Cricetinae | 1 | 1986 | 2424 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2005 | 15609 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1975 | 3743 | 0.000 |
Why?
|
| Cell Count | 1 | 1986 | 1834 | 0.000 |
Why?
|
| International Cooperation | 1 | 1988 | 1422 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1988 | 15498 | 0.000 |
Why?
|
| Pregnancy Trimester, First | 1 | 1986 | 908 | 0.000 |
Why?
|
| Hematuria | 1 | 1982 | 232 | 0.000 |
Why?
|
| Health Status | 1 | 1994 | 4076 | 0.000 |
Why?
|
| Endocarditis | 1 | 1985 | 348 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 4242 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1979 | 175 | 0.000 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1981 | 294 | 0.000 |
Why?
|
| Logistic Models | 1 | 1994 | 13248 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1979 | 29 | 0.000 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 1979 | 41 | 0.000 |
Why?
|
| Myelitis | 1 | 1979 | 49 | 0.000 |
Why?
|
| Cranial Nerves | 1 | 1979 | 98 | 0.000 |
Why?
|
| Chorea | 1 | 1979 | 79 | 0.000 |
Why?
|
| Hemiplegia | 1 | 1979 | 136 | 0.000 |
Why?
|
| Meningoencephalitis | 1 | 1979 | 83 | 0.000 |
Why?
|
| Cell Division | 1 | 1986 | 4457 | 0.000 |
Why?
|
| Patient Isolation | 1 | 1979 | 100 | 0.000 |
Why?
|
| Polyneuropathies | 1 | 1979 | 137 | 0.000 |
Why?
|
| Proteins | 1 | 1992 | 6030 | 0.000 |
Why?
|
| Immunologic Memory | 1 | 1984 | 1355 | 0.000 |
Why?
|
| Developmental Disabilities | 1 | 1986 | 1509 | 0.000 |
Why?
|
| Infant, Premature | 1 | 1986 | 2107 | 0.000 |
Why?
|
| Cold Temperature | 1 | 1979 | 785 | 0.000 |
Why?
|
| Complement System Proteins | 1 | 1979 | 734 | 0.000 |
Why?
|
| Quality of Life | 1 | 1997 | 13359 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1979 | 1031 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1984 | 6339 | 0.000 |
Why?
|
| Neoplasms | 1 | 1979 | 22131 | 0.000 |
Why?
|
| Mass Screening | 1 | 1981 | 5425 | 0.000 |
Why?
|